Douglas Pharmaceuticals Research Development Facility

Douglas Pharmaceuticals Research Development Facility

Douglas Pharmaceuticals Research Development Facility

Client Leighs Construction
Location Auckland
Services Project Planning
Value $35 million
 

New Zealand’s largest pharmaceuticals company is building a new state of the art 4,500m² research and development facility adjacent to their existing headquarters in Auckland.

Inovo has worked closely with the main contractor, providing a comprehensive detailed construction programme which is maintained and updated as the project progresses.

The new facility will house 120 people over three levels and will focus on the development of specialty generic medicines, including clinical trial studies. A key feature of the proposed building is the skybridge, linking the new facility to the manufacturing warehouse and offices, and functioning as both internal access between buildings and a screen for the old structures behind it.